Prednisolone Acetate
Commercial
Anti-inflammatory
IP/ BP / USP / EP
52 – 21 – 1
DMF Available
ANVISA
Application - ophthalmic solution, injections, suspension
Drug Description
Prednisolone acetate is indicated as an anti-inflammatory or immunosuppressive agent for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, or infectious conditions.5 Prednisolone acetate is also indicated in organ transplant patients, as well as endocrine or neoplastic conditions.

